Research ArticleArticle
Mycophenolate Mofetil Improves Lung Function in Connective Tissue Disease-associated Interstitial Lung Disease
Aryeh Fischer, Kevin K. Brown, Roland M. Du Bois, Stephen K. Frankel, Gregory P. Cosgrove, Evans R. Fernandez-Perez, Tristan J. Huie, Mahalakshmi Krishnamoorthy, Richard T. Meehan, Amy L. Olson, Joshua J. Solomon and Jeffrey J. Swigris
The Journal of Rheumatology March 2013, jrheum.121043; DOI: https://doi.org/10.3899/jrheum.121043
Aryeh Fischer
From the Autoimmune and Interstitial Lung Disease Program, National Jewish Health, Denver, Colorado, USA; and the Imperial College, London, UK. Dr. Swigris is supported in part by a Career Development Award from the US National Institutes of Health (K23 HL092227). A. Fischer, MD; K.K. Brown, MD, Autoimmune and Interstitial Lung Disease Program, National Jewish Health; R.M. du Bois, MD, Imperial College; S.K. Frankel, MD; G.P. Cosgrove, MD; E.R. Fernandez-Perez, MD; T.J. Huie, MD; M. Krishnamoorthy, MD; R.T. Meehan, MD; A.L. Olson, MD; J.J. Solomon, MD; J.J. Swigris, DO, Autoimmune and Interstitial Lung Disease Program, National Jewish Health. Address correspondence to Dr. A. Fischer, Autoimmune and Interstitial Lung Disease Program, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, Colorado 80206, USA. E-mail: fischera@njhealth.org Accepted for publication December 20, 2012.
Kevin K. Brown
From the Autoimmune and Interstitial Lung Disease Program, National Jewish Health, Denver, Colorado, USA; and the Imperial College, London, UK. Dr. Swigris is supported in part by a Career Development Award from the US National Institutes of Health (K23 HL092227). A. Fischer, MD; K.K. Brown, MD, Autoimmune and Interstitial Lung Disease Program, National Jewish Health; R.M. du Bois, MD, Imperial College; S.K. Frankel, MD; G.P. Cosgrove, MD; E.R. Fernandez-Perez, MD; T.J. Huie, MD; M. Krishnamoorthy, MD; R.T. Meehan, MD; A.L. Olson, MD; J.J. Solomon, MD; J.J. Swigris, DO, Autoimmune and Interstitial Lung Disease Program, National Jewish Health. Address correspondence to Dr. A. Fischer, Autoimmune and Interstitial Lung Disease Program, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, Colorado 80206, USA. E-mail: fischera@njhealth.org Accepted for publication December 20, 2012.
Roland M. Du Bois
From the Autoimmune and Interstitial Lung Disease Program, National Jewish Health, Denver, Colorado, USA; and the Imperial College, London, UK. Dr. Swigris is supported in part by a Career Development Award from the US National Institutes of Health (K23 HL092227). A. Fischer, MD; K.K. Brown, MD, Autoimmune and Interstitial Lung Disease Program, National Jewish Health; R.M. du Bois, MD, Imperial College; S.K. Frankel, MD; G.P. Cosgrove, MD; E.R. Fernandez-Perez, MD; T.J. Huie, MD; M. Krishnamoorthy, MD; R.T. Meehan, MD; A.L. Olson, MD; J.J. Solomon, MD; J.J. Swigris, DO, Autoimmune and Interstitial Lung Disease Program, National Jewish Health. Address correspondence to Dr. A. Fischer, Autoimmune and Interstitial Lung Disease Program, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, Colorado 80206, USA. E-mail: fischera@njhealth.org Accepted for publication December 20, 2012.
Stephen K. Frankel
From the Autoimmune and Interstitial Lung Disease Program, National Jewish Health, Denver, Colorado, USA; and the Imperial College, London, UK. Dr. Swigris is supported in part by a Career Development Award from the US National Institutes of Health (K23 HL092227). A. Fischer, MD; K.K. Brown, MD, Autoimmune and Interstitial Lung Disease Program, National Jewish Health; R.M. du Bois, MD, Imperial College; S.K. Frankel, MD; G.P. Cosgrove, MD; E.R. Fernandez-Perez, MD; T.J. Huie, MD; M. Krishnamoorthy, MD; R.T. Meehan, MD; A.L. Olson, MD; J.J. Solomon, MD; J.J. Swigris, DO, Autoimmune and Interstitial Lung Disease Program, National Jewish Health. Address correspondence to Dr. A. Fischer, Autoimmune and Interstitial Lung Disease Program, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, Colorado 80206, USA. E-mail: fischera@njhealth.org Accepted for publication December 20, 2012.
Gregory P. Cosgrove
From the Autoimmune and Interstitial Lung Disease Program, National Jewish Health, Denver, Colorado, USA; and the Imperial College, London, UK. Dr. Swigris is supported in part by a Career Development Award from the US National Institutes of Health (K23 HL092227). A. Fischer, MD; K.K. Brown, MD, Autoimmune and Interstitial Lung Disease Program, National Jewish Health; R.M. du Bois, MD, Imperial College; S.K. Frankel, MD; G.P. Cosgrove, MD; E.R. Fernandez-Perez, MD; T.J. Huie, MD; M. Krishnamoorthy, MD; R.T. Meehan, MD; A.L. Olson, MD; J.J. Solomon, MD; J.J. Swigris, DO, Autoimmune and Interstitial Lung Disease Program, National Jewish Health. Address correspondence to Dr. A. Fischer, Autoimmune and Interstitial Lung Disease Program, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, Colorado 80206, USA. E-mail: fischera@njhealth.org Accepted for publication December 20, 2012.
Evans R. Fernandez-Perez
From the Autoimmune and Interstitial Lung Disease Program, National Jewish Health, Denver, Colorado, USA; and the Imperial College, London, UK. Dr. Swigris is supported in part by a Career Development Award from the US National Institutes of Health (K23 HL092227). A. Fischer, MD; K.K. Brown, MD, Autoimmune and Interstitial Lung Disease Program, National Jewish Health; R.M. du Bois, MD, Imperial College; S.K. Frankel, MD; G.P. Cosgrove, MD; E.R. Fernandez-Perez, MD; T.J. Huie, MD; M. Krishnamoorthy, MD; R.T. Meehan, MD; A.L. Olson, MD; J.J. Solomon, MD; J.J. Swigris, DO, Autoimmune and Interstitial Lung Disease Program, National Jewish Health. Address correspondence to Dr. A. Fischer, Autoimmune and Interstitial Lung Disease Program, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, Colorado 80206, USA. E-mail: fischera@njhealth.org Accepted for publication December 20, 2012.
Tristan J. Huie
From the Autoimmune and Interstitial Lung Disease Program, National Jewish Health, Denver, Colorado, USA; and the Imperial College, London, UK. Dr. Swigris is supported in part by a Career Development Award from the US National Institutes of Health (K23 HL092227). A. Fischer, MD; K.K. Brown, MD, Autoimmune and Interstitial Lung Disease Program, National Jewish Health; R.M. du Bois, MD, Imperial College; S.K. Frankel, MD; G.P. Cosgrove, MD; E.R. Fernandez-Perez, MD; T.J. Huie, MD; M. Krishnamoorthy, MD; R.T. Meehan, MD; A.L. Olson, MD; J.J. Solomon, MD; J.J. Swigris, DO, Autoimmune and Interstitial Lung Disease Program, National Jewish Health. Address correspondence to Dr. A. Fischer, Autoimmune and Interstitial Lung Disease Program, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, Colorado 80206, USA. E-mail: fischera@njhealth.org Accepted for publication December 20, 2012.
Mahalakshmi Krishnamoorthy
From the Autoimmune and Interstitial Lung Disease Program, National Jewish Health, Denver, Colorado, USA; and the Imperial College, London, UK. Dr. Swigris is supported in part by a Career Development Award from the US National Institutes of Health (K23 HL092227). A. Fischer, MD; K.K. Brown, MD, Autoimmune and Interstitial Lung Disease Program, National Jewish Health; R.M. du Bois, MD, Imperial College; S.K. Frankel, MD; G.P. Cosgrove, MD; E.R. Fernandez-Perez, MD; T.J. Huie, MD; M. Krishnamoorthy, MD; R.T. Meehan, MD; A.L. Olson, MD; J.J. Solomon, MD; J.J. Swigris, DO, Autoimmune and Interstitial Lung Disease Program, National Jewish Health. Address correspondence to Dr. A. Fischer, Autoimmune and Interstitial Lung Disease Program, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, Colorado 80206, USA. E-mail: fischera@njhealth.org Accepted for publication December 20, 2012.
Richard T. Meehan
From the Autoimmune and Interstitial Lung Disease Program, National Jewish Health, Denver, Colorado, USA; and the Imperial College, London, UK. Dr. Swigris is supported in part by a Career Development Award from the US National Institutes of Health (K23 HL092227). A. Fischer, MD; K.K. Brown, MD, Autoimmune and Interstitial Lung Disease Program, National Jewish Health; R.M. du Bois, MD, Imperial College; S.K. Frankel, MD; G.P. Cosgrove, MD; E.R. Fernandez-Perez, MD; T.J. Huie, MD; M. Krishnamoorthy, MD; R.T. Meehan, MD; A.L. Olson, MD; J.J. Solomon, MD; J.J. Swigris, DO, Autoimmune and Interstitial Lung Disease Program, National Jewish Health. Address correspondence to Dr. A. Fischer, Autoimmune and Interstitial Lung Disease Program, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, Colorado 80206, USA. E-mail: fischera@njhealth.org Accepted for publication December 20, 2012.
Amy L. Olson
From the Autoimmune and Interstitial Lung Disease Program, National Jewish Health, Denver, Colorado, USA; and the Imperial College, London, UK. Dr. Swigris is supported in part by a Career Development Award from the US National Institutes of Health (K23 HL092227). A. Fischer, MD; K.K. Brown, MD, Autoimmune and Interstitial Lung Disease Program, National Jewish Health; R.M. du Bois, MD, Imperial College; S.K. Frankel, MD; G.P. Cosgrove, MD; E.R. Fernandez-Perez, MD; T.J. Huie, MD; M. Krishnamoorthy, MD; R.T. Meehan, MD; A.L. Olson, MD; J.J. Solomon, MD; J.J. Swigris, DO, Autoimmune and Interstitial Lung Disease Program, National Jewish Health. Address correspondence to Dr. A. Fischer, Autoimmune and Interstitial Lung Disease Program, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, Colorado 80206, USA. E-mail: fischera@njhealth.org Accepted for publication December 20, 2012.
Joshua J. Solomon
From the Autoimmune and Interstitial Lung Disease Program, National Jewish Health, Denver, Colorado, USA; and the Imperial College, London, UK. Dr. Swigris is supported in part by a Career Development Award from the US National Institutes of Health (K23 HL092227). A. Fischer, MD; K.K. Brown, MD, Autoimmune and Interstitial Lung Disease Program, National Jewish Health; R.M. du Bois, MD, Imperial College; S.K. Frankel, MD; G.P. Cosgrove, MD; E.R. Fernandez-Perez, MD; T.J. Huie, MD; M. Krishnamoorthy, MD; R.T. Meehan, MD; A.L. Olson, MD; J.J. Solomon, MD; J.J. Swigris, DO, Autoimmune and Interstitial Lung Disease Program, National Jewish Health. Address correspondence to Dr. A. Fischer, Autoimmune and Interstitial Lung Disease Program, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, Colorado 80206, USA. E-mail: fischera@njhealth.org Accepted for publication December 20, 2012.
Jeffrey J. Swigris
From the Autoimmune and Interstitial Lung Disease Program, National Jewish Health, Denver, Colorado, USA; and the Imperial College, London, UK. Dr. Swigris is supported in part by a Career Development Award from the US National Institutes of Health (K23 HL092227). A. Fischer, MD; K.K. Brown, MD, Autoimmune and Interstitial Lung Disease Program, National Jewish Health; R.M. du Bois, MD, Imperial College; S.K. Frankel, MD; G.P. Cosgrove, MD; E.R. Fernandez-Perez, MD; T.J. Huie, MD; M. Krishnamoorthy, MD; R.T. Meehan, MD; A.L. Olson, MD; J.J. Solomon, MD; J.J. Swigris, DO, Autoimmune and Interstitial Lung Disease Program, National Jewish Health. Address correspondence to Dr. A. Fischer, Autoimmune and Interstitial Lung Disease Program, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, Colorado 80206, USA. E-mail: fischera@njhealth.org Accepted for publication December 20, 2012.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Mycophenolate Mofetil Improves Lung Function in Connective Tissue Disease-associated Interstitial Lung Disease
Aryeh Fischer, Kevin K. Brown, Roland M. Du Bois, Stephen K. Frankel, Gregory P. Cosgrove, Evans R. Fernandez-Perez, Tristan J. Huie, Mahalakshmi Krishnamoorthy, Richard T. Meehan, Amy L. Olson, Joshua J. Solomon, Jeffrey J. Swigris
The Journal of Rheumatology Mar 2013, jrheum.121043; DOI: 10.3899/jrheum.121043
Mycophenolate Mofetil Improves Lung Function in Connective Tissue Disease-associated Interstitial Lung Disease
Aryeh Fischer, Kevin K. Brown, Roland M. Du Bois, Stephen K. Frankel, Gregory P. Cosgrove, Evans R. Fernandez-Perez, Tristan J. Huie, Mahalakshmi Krishnamoorthy, Richard T. Meehan, Amy L. Olson, Joshua J. Solomon, Jeffrey J. Swigris
The Journal of Rheumatology Mar 2013, jrheum.121043; DOI: 10.3899/jrheum.121043